MEPROBAMATE AND ASPIRIN Drug Patent Profile
✉ Email this page to a colleague
When do Meprobamate And Aspirin patents expire, and when can generic versions of Meprobamate And Aspirin launch?
Meprobamate And Aspirin is a drug marketed by Par Pharm and is included in one NDA.
The generic ingredient in MEPROBAMATE AND ASPIRIN is aspirin; meprobamate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; meprobamate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEPROBAMATE AND ASPIRIN?
- What are the global sales for MEPROBAMATE AND ASPIRIN?
- What is Average Wholesale Price for MEPROBAMATE AND ASPIRIN?
Summary for MEPROBAMATE AND ASPIRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | MEPROBAMATE AND ASPIRIN at DailyMed |
US Patents and Regulatory Information for MEPROBAMATE AND ASPIRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | MEPROBAMATE AND ASPIRIN | aspirin; meprobamate | TABLET;ORAL | 089126-001 | Aug 19, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
